Life Sciences Job Report Shows Growth Slowing, but Firms Still Invest in Talent

As the United States has long been a life sciences leader, the health of the life sciences sector is a pretty good indicator of overall prosperity and innovation.

The Life Sciences Workforce Collaborative, in conjunction with Teconomy Partners LLC, created the seventh Life Sciences Workforce Trends Report. The report includes survey data and analysis from over 500 life sciences companies, interviews with over 200 industry executives, and 2.9 million job postings from 2021-2024 to identify and investigate trends.

Here are four key trends about the U.S. life sciences sector to know.

1. Hiring is down slightly.

“The U.S. life sciences industry is experiencing lower hiring volumes and a modest overall contraction,” says the report. However, the situation differs from company to company, with gains more in pharmaceuticals and bioscience-related distribution, and losses in medical devices, research, and agriculture.

This industry-wide contraction follows five years of notable yearly growth from 2017-2022, which started to level off in recent years. “In 2023, industry growth slowed significantly, with net job increases reaching just 1.2% after averaging 4.5% annual growth over the preceding five years,” the report notes. “In 2024, U.S. life sciences employers shed a modest number of jobs with industry employment down by 0.3% over the year.”

Wage increases are slowing, as well: “The share of companies reporting wage increases of 10% or greater has declined from 37% of firms in the 2023 survey to 16% in the 2025 survey. Where significant wage increases have occurred, inflation and competition for talent remain the most important factors driving those increases.”

What is driving this contraction? Industry leaders mentioned four points:

  1. Inflation,
  2. Global economic uncertainty,
  3. Fundraising and investment difficulties, and
  4. Higher job retention.

Workforce talent attraction and retention have evolved to fit the landscape. The industry is prioritizing:

  • A narrower emphasis on “strategic” hires,
  • Utilizing contractors and consultants more,
  • Targeting cost reductions, for example, reducing automation of investments, and
  • Investing more in existing employees’ development.

One notable feature of the slowed hiring, however, is that companies are reporting fewer challenges when it comes to hiring for skilled key roles.

2. AI is changing the game.

Not surprisingly, artificial intelligence (AI) is having a disruptive effect on life sciences in ways both positive and negative. As a result, employees and leadership are finding themselves needing to learn.

“Today, AI is beginning to decipher the patterns that govern the behavior of biological systems,” wrote the National Security Commission on Emerging Biotechnology (NSCEB) in April 2025. “Thanks to AI’s tremendous modeling power, in the future we will no longer need to know (or expend the human effort and time determining) exactly how a biological system works in order to harness it. Instead, we will be able to program cells as we program computers, accurately and precisely engineering biology in order to achieve desired results.”

AI automation in particular is dictating who will be the employees of tomorrow, their skills, and what jobs will transition to automation, as well as how companies are investing in employees. “To make AI and automation work, companies need the right infrastructure, skilled people, and internal systems to support them,” the report says.

But while many claim “machines are taking our jobs,” the report found a different reality: “AI and automation are reshaping the workforce by transforming and enhancing roles rather than simply replacing them,” the report explains. “Companies are also focused on rethinking job design and integrating advanced technologies across various business operations.”

3. Companies are prioritizing upskilling.

“Companies are placing a major emphasis on incumbent worker upskilling, reskilling, and other skills training and development in response to ongoing digital transformations and regulatory changes,” the report explains. This is not altogether surprising, as upskilling and constant learning are critically important in the life sciences. What is interesting is the variety of skills needed.

For example, AI literacy was found to be more important on the healthcare side of the life sciences industry, with both pharmaceuticals and research noting its importance.

“AI is well-suited for biology; once models can become as fluent in DNA and other biological molecules as they now are in human language, the results will be profound,” wrote the NSCEB. “Soon, decades of biotechnology breakthroughs will happen in mere years.”

Yet, data management and quality control skills are more important in medical devices and agriculture.

The spread of technology acumen emphasizes that automation and deep data analysis are not only here to stay, but are poised to continue changing the industry landscape for years to come.

It is not surprising that industry is engaging with prospective talent earlier and more in depth.

4. Early student engagement is up.

The life sciences industry has always prioritized early student engagement, but changes in the current landscape have seen companies significantly increase their level of involvement in STEM education and supporting early talent pipelines since the 2023 survey. Senior HR leaders “indicate much greater levels of involvement in student-focused STEM pipeline initiatives, particularly with respect to K-8 and high school students, including classroom engagement, mentorships, and other initiatives,” as well as increases in classroom engagement.

Classroom engagement, such as guest lectures and after-school programming, is also up since 2023, increasing “12% to 56% at the K-8 level and from 16% to 49% in U.S. high schools.”

Student mentorship is also on the rise, with 17% of companies offering mentorship opportunities to K–12 students (compared to 5% in previous years) and 22% for high schoolers (compared to 12%).

While companies may have been less engaged with early student talent during the COVID years, the recent rates of engagement are still significant.

These high rates of engagement hold for post-secondary students as well, though they are, not surprisingly, more often offered internships and co-op program opportunities, with some companies even offering apprenticeships.

“Nearly eight in ten companies reported hiring interns from four-year colleges and universities,” writes the report, “and nearly two in three companies report hiring interns from community colleges in the latest industry hiring survey.”

The investment in young talent by life sciences industries bodes well for keeping pace with the increasingly rapid pace of technology and development.

About The Author

Clary Estes

Clary Estes has worked as a journalist and writer since 2011 in a variety of fields. Her primary field of work has been in healthcare, focusing on the opioid epidemic and the COVID-19 pandemic, as well as other issues and topics. She has worked internationally in a number of languages and for a variety of publications. She is currently based out of Los Angeles.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.